95 related articles for article (PubMed ID: 3000298)
1. [The effect of lithium carbonate against leukopenia during systemic chemotherapy in patients with small cell carcinoma of the lung].
Tamura S; Fujikura M; Takahashi S; Maebo A; Nakano T; Yamada W; Fujii J; Nabeshima K; Hada T; Higashino K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2338-44. PubMed ID: 3000298
[TBL] [Abstract][Full Text] [Related]
2. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy.
Lyman GH; Williams CC; Preston D
N Engl J Med; 1980 Jan; 302(5):257-60. PubMed ID: 6243170
[TBL] [Abstract][Full Text] [Related]
3. [Lithium carbonate--a preventive agent against leukopenia during cytostatic therapy].
Lahousen M; Pickel H; Haas J
Wien Klin Wochenschr; 1984 Oct; 96(19):739-41. PubMed ID: 6441351
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung.
Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S
Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
[TBL] [Abstract][Full Text] [Related]
9. [Randomized systemic chemotherapy using two or three drug combination for small cell lung cancer (SCLC)].
Eguchi K; Shimizu E; Shinkai T; Tominaga K; Saijo N; Shimabukuro Z; Shibuya M; Niitani H
Gan No Rinsho; 1984 Feb; 30(2):115-21. PubMed ID: 6323783
[TBL] [Abstract][Full Text] [Related]
10. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
11. [Several years of follow-up and results of chemotherapy of small cell bronchial carcinoma].
Gatzemeier U
Prax Klin Pneumol; 1983 Apr; 37(4):144-7. PubMed ID: 6306636
[No Abstract] [Full Text] [Related]
12. [Small cell carcinoma of the lung. Combined therapy with cytostatics].
Seim H; Gulsvik A; Tausjø J; Lexow P
Tidsskr Nor Laegeforen; 1985 Oct; 105(28):1956-8. PubMed ID: 3000018
[No Abstract] [Full Text] [Related]
13. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
Littlewood TJ; Smith AP; Anderson G; Chappell AG; James KW
Eur J Respir Dis; 1985 Oct; 67(4):294-300. PubMed ID: 3000808
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
16. [Cyclic alternating combination chemotherapy of small cell carcinoma of the lung].
Urata A; Ota K; Nishimura M; Sugiura T; Yamamoto N
Gan To Kagaku Ryoho; 1986 Feb; 13(2):286-92. PubMed ID: 3004365
[TBL] [Abstract][Full Text] [Related]
17. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
18. [A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung].
Adachi K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Nakata H; Tada A; Aiba K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1617-22. PubMed ID: 6089668
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of small cell lung cancer].
Komiya T; Takada M
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
[TBL] [Abstract][Full Text] [Related]
20. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
Yanagawa H; Bando H; Takishita Y
Anticancer Res; 1995; 15(2):613-6. PubMed ID: 7539241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
